2 active not recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Active not recruiting 2 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases V001-BCMA - Recurrent or Refractory Systemic Lupus Erythematosus, Recurrent or Refractory IgG4 Related Diseases | Early Phase 1 | Active not recruiting | Tongji Hospital | 45 | 2025-11-04 | 2026-09-17 |
| TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Intensity-Modulated Radiation Therapy - Systemic Scleroderma | Early Phase 1 | Active not recruiting | City of Hope Medical Center | 15 | 2022-02-24 | 2026-08-27 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Immunoglobulin G4-Related Disease (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Recurrence (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases, Vascular (1) · Systemic Vasculitis (1)
Cyclophosphamide (1) · Radiotherapy, Intensity-Modulated (1) · Stem Cell Transplantation (1) · Whole-Body Irradiation (1)
City of Hope Medical Center (1) · Tongji Hospital (1)
China (1) · United States (1)
Jeffrey Y Wong (1)